A postdoctoral fellowship in the field of cancer immunotherapy to work on 

Safety-Enhanced Chimeric Antigen Receptors (SECAR)

will be available for a period of 30 months starting from November 2025. This postdoctoral fellowship is funded by Helse Sør -Øst.

Link to full annonce: Advert - Webcruiter

We are looking for a motivated and hard-working Master student for the following project:

Production and Validation of next generation genome edited 1XX_CAR

Candidates should be eligible for a Master at the University of Oslo (information here). Note that this is an unpaid position.

More details about the project will soon be available or contact Sébastien Wälchli.